Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

8.74
Delayed Data
As of Jul 31
 +0.01 / +0.11%
Today’s Change
8.42
Today|||52-Week Range
18.25
-48.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.00160.6M4.4M4.4M
 
 
 
 
Depreciation And Amortization452.0K447.0K406.0K354.0K
 
 
 
 
 
 
Operating ExpensesGross Income-452.0K------
 
 
General Expenses34.8M52.5M43.1M96.6M
 
 
 
 
 
Research And Development28.2M44.9M36.1M88.4M
 
 
 
 
 
Total Operating Expenses35.2M52.9M43.5M97.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.2M107.7M-39.1M-92.6M
 
 
 
 
 
Interest Expense On Debt2.9M4.5M1.0M647.0K
 
 
 
 
 
Other Expenses0.000.000.00-40.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.0M103.2M-40.2M-93.3M
 
 
 
 
 
Income Taxes0.000.00-183.0K0.00
 
 
Net Income-38.0M101.1M-40.3M-93.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.5M48.6M48.8M48.9M
 
 
 
 
 
Shares To Calculate EPS Diluted48.5M49.7M48.8M48.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78$2.03-$0.83-$1.91
 
 
 
 
 
EPS Diluted-$0.78$2.03-$0.83-$1.91